BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34715507)

  • 1. Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables.
    Hackenberg A; Battilana B; Hebeisen M; Steinfeld R; Khan N
    Eur J Paediatr Neurol; 2021 Nov; 35():130-136. PubMed ID: 34715507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between moyamoya disease and moyamoya syndrome in Israel.
    Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.
    Po' C; Nosadini M; Zedde M; Pascarella R; Mirone G; Cicala D; Rosati A; Cosi A; Toldo I; Colombatti R; Martelli P; Iodice A; Accorsi P; Giordano L; Savasta S; Foiadelli T; Sanfilippo G; Lafe E; Thyrion FZ; Polonara G; Campa S; Raviglione F; Scelsa B; Bova SM; Greco F; Cordelli DM; Cirillo L; Toni F; Baro V; Causin F; Frigo AC; Suppiej A; Sainati L; Azzolina D; Agostini M; Cesaroni E; De Carlo L; Di Rosa G; Esposito G; Grazian L; Morini G; Nicita F; Operto FF; Pruna D; Ragazzi P; Rollo M; Spalice A; Striano P; Skabar A; Lanterna LA; Carai A; Marras CE; Manara R; Sartori S
    Front Pediatr; 2022; 10():892445. PubMed ID: 35601411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures in Pediatric Moyamoya: Risk Factors and Functional Outcomes.
    Gatti JR; Penn R; Ahmad SA; Sun LR
    Pediatr Neurol; 2023 Aug; 145():36-40. PubMed ID: 37271055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
    Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
    World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
    Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
    J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease.
    Kimiwada T; Hayashi T; Shirane R; Tominaga T
    J Neurosurg Pediatr; 2018 Jun; 21(6):632-638. PubMed ID: 29624146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
    Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
    Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort.
    Bouchaala W; Laroussi S; Mzid Y; Maaloul I; Jallouli O; Zouari S; Ben Nsir S; Mnif Z; Kammoun F; Triki C
    Pediatr Neurol; 2024 Jan; 150():3-9. PubMed ID: 37925769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease.
    Funaki T; Takahashi JC; Takagi Y; Yoshida K; Araki Y; Kikuchi T; Kataoka H; Iihara K; Miyamoto S
    J Neurosurg Pediatr; 2013 Dec; 12(6):626-32. PubMed ID: 24138143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.
    Ren B; Zhang ZS; Liu WW; Bao XY; Li DS; Han C; Xian P; Zhao F; Wang H; Wang H; Duan L
    J Neurosurg; 2016 Aug; 125(2):308-14. PubMed ID: 26745491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.